Summary & Overview
CPT 81025: Urine Pregnancy Test, Visually Read by Analyst
CPT code 81025 identifies a laboratory-performed urine pregnancy test that the laboratory analyst reads visually from a manual kit or methodology. This code is used nationally to bill for in-lab qualitative pregnancy screening where a direct visual endpoint is interpreted by a trained analyst rather than by automated analyzers. Accurate coding for this service matters for clinical workflows, billing compliance, and quality measurement across outpatient clinics, hospital laboratories, and reference labs.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the assay, common service settings, and payer coverage considerations. The publication outlines typical billing modifiers and related administrative details where available, and it highlights what clinicians and billing staff need to document to support use of CPT code 81025.
The content provides national-level perspectives on coding practices, payer presence, and operational context for point-of-care and manual laboratory pregnancy testing. Data not available in the input is explicitly noted where applicable; the focus remains on clarifying the clinical service, expected sites of service, and the role of this CPT code in routine laboratory practice.
Billing Code Overview
CPT code 81025 describes a urine pregnancy test performed by a laboratory analyst using a visually read kit or methodology. The test yields a direct visual readout interpreted by the analyst rather than requiring automated instrumentation.
Service type: Laboratory diagnostic test (point-of-care or laboratory-performed manual assay)
Typical site of service: Clinical laboratory, hospital laboratory, outpatient clinic, or other facility where trained laboratory personnel perform manual urine pregnancy testing.
Clinical & Coding Specifications
Clinical Context
A typical patient is a reproductive-age female presenting to an outpatient clinic, urgent care, emergency department, or preoperative area for evaluation of possible pregnancy. Common presentations include missed menses, lower abdominal pain, irregular bleeding, or pre-procedural screening prior to radiography or medications. The clinical workflow: the patient is registered, a urine sample is collected and labeled, and a laboratory technologist or trained clinical staff performs a visually read urine pregnancy immunoassay using a point-of-care kit. The analyst reads the qualitative result (positive, negative, or invalid), documents the result in the medical record, and communicates positive results to the treating clinician for further evaluation and order of quantitative serum hCG if needed. Point-of-care documentation includes specimen source, date/time, test kit lot number, and the analyst’s signature. Typical sites of service: outpatient clinics, urgent care centers, emergency departments, ambulatory surgery centers, and hospital laboratories performing point-of-care pregnancy testing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when an E/M visit is performed and documented separately from the pregnancy test (e.g., evaluation for abdominal pain). |